COMMODORE CAPITAL
COMMODORE CAPITAL LP Legal Name
Adviser information for COMMODORE CAPITAL last updated from Form ADV on March 22nd, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 12 |
|---|---|
| Investment Advisory/Research | 6 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 3 | $1.4B |
| Non-Discretionary | 0 | $0 |
| Total | 3 | $1.4B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 3 | $1.4B |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 66 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
444 MADISON AVENUE35TH FLOOR
NEW YORK
NY
United States
Monday - Friday, 9AM-5PM
Tel: 212-256-8600, Fax: None
Chief Compliance Officer
AMEYA BAPAT
GENERAL COUNSEL & CHIEF OPERATING OFFICER
444 MADISON AVENUE
35TH FLOOR
NEW YORK
NY
United States
Tel:
212-256-8600
A*****@*******************M
(Full email address available in API data)
Industry Affiliates
| COMMODORE CAPITAL DOMESTIC GP LP | Other investment adviser, including financial plannersSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| COMMODORE CAPITAL MASTER LP | Hedge Fund | $1,356.4M | $5.0M | 136 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| Kramarz, Michael, Jonathan | Individual | – | MANAGING PARTNER | 06/2019 | < 5% |
| Atkinson, Robert Egen, Turrell | Individual | – | MANAGING PARTNER | 06/2019 | < 5% |
| COMMODORE CAPITAL GP LLC | Domestic Entity | – | GENERAL PARTNER | 06/2019 | < 5% |
| COMMODORE CAPITAL HOLDINGS LP | Domestic Entity | – | LIMITED PARTNER | 06/2019 | > 75% |
| Kramarz, Michael, Jonathan | Individual | COMMODORE CAPITAL HOLDINGS LP | LIMITED PARTNER | 06/2019 | 25-50% |
| Atkinson, Robert Egen, Turrell | Individual | COMMODORE CAPITAL HOLDINGS LP | LIMITED PARTNER | 06/2019 | 25-50% |
| Kramarz, Michael, Jonathan | Individual | COMMODORE CAPITAL GP LLC | MEMBER | 06/2019 | 25-50% |
| Atkinson, Robert Egen, Turrell | Individual | COMMODORE CAPITAL GP LLC | MEMBER | 06/2019 | 25-50% |
| Bapat, Ameya, Vikas | Individual | – | CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER, GENERAL COUNSEL | 03/2022 | < 5% |
| Pandya, Anand, Bharat | Individual | – | CHIEF FINANCIAL OFFICER | 02/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| ARCA BIOPHARMA INC | COM | 2M | 414K | – |
| ABIVAX SA | SPONSORED ADS | 17M | 1M | – |
| ALKERMES PLC | SHS | 33M | 1M | – |
| APOGEE THERAPEUTICS INC | COM | 11M | 290K | – |
| ARVINAS INC | COM | 50M | 2M | – |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 4M | 1M | – |
| AVALO THERAPEUTICS INC | COM NEW | 499K | 40K | – |
| CABALETTA BIO INC | COM | 8M | 1M | – |
| C4 THERAPEUTICS INC | COM STK | 16M | 3M | – |
| CELCUITY INC | COM | 24M | 1M | – |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 53M | 1M | – |
| COGENT BIOSCIENCES INC | COM | 82M | 10M | – |
| ENLIVEN THERAPEUTICS INC | COM | 93M | 4M | – |
| HELIX ACQUISITION CORP II | CL A ORD SHS | 5M | 500K | – |
| IMMUNOVANT INC | COM | 20M | 751K | – |
| KURA ONCOLOGY INC | COM | 33M | 2M | – |
| MERUS N V | COM | 189M | 3M | – |
| MIND MEDICINE MINDMED INC | COM NEW | 52M | 7M | – |
| NEUROGENE INC | COM | 7M | 200K | – |
| NKARTA INC | COM | 25M | 4M | – |
| NUVALENT INC | COM | 113M | 1M | – |
| ORIC PHARMACEUTICALS INC | COM | 14M | 2M | – |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | 8M | 750K | – |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46M | 5M | – |
| PHARVARIS N V | COM | 34M | 2M | – |
| RHYTHM PHARMACEUTICALS INC | COM | 50M | 1M | – |
| SOLENO THERAPEUTICS INC | COM | 58M | 1M | – |
| SPYRE THERAPEUTICS INC | COM NEW | 47M | 2M | – |
| SYNDAX PHARMACEUTICALS INC | COM | 17M | 825K | – |
| THIRD HARMONIC BIO INC | COM | 20M | 2M | – |
| VAXCYTE INC | COM | 99M | 1M | – |
| VERA THERAPEUTICS INC | CL A | 90M | 2M | – |
| VIRIDIAN THERAPEUTICS INC | COM | 33M | 3M | – |
| VISTAGEN THERAPEUTICS INC | COM | 5M | 2M | – |
| XENON PHARMACEUTICALS INC | COM | 107M | 3M | – |